Literature DB >> 11994043

The practice of splitting tablets: cost and therapeutic aspects.

John Bachynsky1, Cheryl Wiens, Krystal Melnychuk.   

Abstract

BACKGROUND: Tablet splitting is used in pharmacy practice to adjust the dose to be administered. It is also being advocated as a method of reducing prescription drug costs.
METHODS: The potential for using this practice as a cost-saving method was examined. The top 200 prescription products in Canada were evaluated for their potential for tablet splitting to reduce costs. The assessment was based on the dosage form (only tablets could be split), availability of dosages in multiples, whether the drug was used for long-term therapy, whether the product was packaged suitably (e.g. oral contraceptives in a therapeutic package), whether pricing structure would allow substantial saving, and the physical nature of the tablets (e.g. whether there were special dose-release characteristics). The products most commonly split in three Canadian pharmacies were compared with the products that had a substantial savings potential. Costs for splitting tablets in the pharmacy and costs of instructing patients to split tablets were calculated.
RESULTS: Savings could be generated from tablet splitting for only 15 of the 200 products. There was little overlap between these 15 products and the products that were most frequently split in the three pharmacies. The costs associated with tablet splitting in the pharmacy were approximately 0.1 Canadian dollars ($Can) per tablet. The cost of instructing a patient to split the tablets was approximately $Can1.
CONCLUSIONS: Tablet splitting appears to have limited usefulness as a cost-reduction strategy. Only a small proportion of products are suitable for splitting and have the potential for savings. There are also costs arising from splitting tablets in the pharmacy, or instructing patients to do so, and from wastage of product. There are also issues such as patient compliance and the risk of an incorrect dose being taken that should be considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994043     DOI: 10.2165/00019053-200220050-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  8 in total

Review 1.  Challenges of prescribing low-dose drug therapy for older people.

Authors:  P A Rochon; J P Clark; J H Gurwitz
Journal:  CMAJ       Date:  1999-04-06       Impact factor: 8.262

Review 2.  Economic factors in the initiation of antihypertensive therapy.

Authors:  I Kawachi
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

3.  Accuracy of tablet splitting.

Authors:  J T McDevitt; A H Gurst; Y Chen
Journal:  Pharmacotherapy       Date:  1998 Jan-Feb       Impact factor: 4.705

4.  Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance.

Authors:  N G Fawell; T L Cookson; S S Scranton
Journal:  Am J Health Syst Pharm       Date:  1999-12-15       Impact factor: 2.637

5.  Broken tablets: does the sum of the parts equal the whole?

Authors:  P Gupta; K Gupta
Journal:  Am J Hosp Pharm       Date:  1988-07

6.  The tablet splitter: barrier to compliance or cost-saving instrument?

Authors:  S M Carr-Lopez; M S Mallett; T Morse
Journal:  Am J Health Syst Pharm       Date:  1995-12-01       Impact factor: 2.637

7.  Splitting tablets in half.

Authors:  M Sedrati; P Arnaud; J E Fontan; F Brion
Journal:  Am J Hosp Pharm       Date:  1994-02-15

8.  Functional ability of patients to manage medication packaging: a survey of geriatric inpatients.

Authors:  P A Atkin; T P Finnegan; S J Ogle; G M Shenfield
Journal:  Age Ageing       Date:  1994-03       Impact factor: 10.668

  8 in total
  12 in total

1.  The frequency of inappropriate tablet splitting in primary care.

Authors:  R Quinzler; C Gasse; A Schneider; P Kaufmann-Kolle; J Szecsenyi; W E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2006-10-06       Impact factor: 2.953

2.  Time series evaluation of an intervention to increase statin tablet splitting by general practitioners.

Authors:  Jennifer M Polinski; Sebastian Schneeweiss; Malcolm Maclure; Blair Marshall; Samuel Ramsden; Colin Dormuth
Journal:  Clin Ther       Date:  2011-02       Impact factor: 3.393

3.  Influence of splitting on dissolution properties of metoprolol tablets.

Authors:  Edina Vranić; Alija Uzunović
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

4.  Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan.

Authors:  Chia-Lin Chou; Chia-Chen Hsu; Chia-Yu Chou; Tzeng-Ji Chen; Li-Fang Chou; Yueh-Ching Chou
Journal:  Int J Clin Pharm       Date:  2015-09-23

5.  Cost-Savings From an Antipsychotic Tablet-Splitting Program.

Authors:  Heather Carey; Mark Fondriest
Journal:  P T       Date:  2017-06

6.  Comparison of some physical parameters of whole and scored lisinopril and lisinopril/hydrochlorthiazide tablets.

Authors:  Edina Vranić; Alija Uzunović
Journal:  Bosn J Basic Med Sci       Date:  2008-11       Impact factor: 3.363

7.  Evaluation of Certain Pharmaceutical Quality Attributes of Lisinopril Split Tablets.

Authors:  Khairi M S Fahelelbom; Moawia M M Al-Tabakha; Nermin A M Eissa; Jeevani Javadi
Journal:  Sci Pharm       Date:  2016-10-11

8.  Prevalence of tablet splitting in a Brazilian tertiary care hospital.

Authors:  Vivianne V Melo; Gessyka R Pereira; Amanda Q Soares; Izabel C Silva; Stephania F Taveira; Marcilio Cunha-Filho; Ricardo N Marreto
Journal:  Pharm Pract (Granada)       Date:  2020-06-02

9.  Association between physician specialty and risk of prescribing inappropriate pill splitting.

Authors:  Chia-Yu Chou; Chia-Chen Hsu; Shu-Chiung Chiang; Chin-Chin Ho; Chia-Lin Chou; Min-Shan Wu; Yuh-Lih Chang; Han-Yi Tsai; Tzeng-Ji Chen; Yueh-Ching Chou
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Issues around the Prescription of Half Tablets in Northern Switzerland: The Irrational Case of Quetiapine.

Authors:  Samuel S Allemann; Delia Bornand; Balthasar Hug; Kurt E Hersberger; Isabelle Arnet
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.